PURA VIDA INVESTMENTS, LLC - Q1 2022 holdings

Add to watchlist

$3.08 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 226 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was - .

All

			Value		Shares		↓ Weighting
	New	MEDTRONIC PLCcall	$44,380,000	–	400,000	+100.0%	1.44%	–
	New	ISHARES TRput	$35,924,000	–	275,700	+100.0%	1.16%	–
	New	BAXTER INTL INCput	$31,016,000	–	400,000	+100.0%	1.01%	–
BIIB	New	BIOGEN INC	$30,987,000	–	147,135	+100.0%	1.00%	–
	New	ZIMMER BIOMET HOLDINGS INCcall	$28,778,000	–	225,000	+100.0%	0.93%	–
	New	JOHNSON & JOHNSONput	$26,585,000	–	150,000	+100.0%	0.86%	–
	New	QUEST DIAGNOSTICS INCput	$25,210,000	–	184,200	+100.0%	0.82%	–
	New	INTUITIVE SURGICAL INCcall	$22,777,000	–	75,500	+100.0%	0.74%	–
	New	ILLUMINA INCcall	$22,711,000	–	65,000	+100.0%	0.74%	–
	New	DENTSPLY SIRONA INCput	$18,113,000	–	368,000	+100.0%	0.59%	–
	New	BOSTON SCIENTIFIC CORPcall	$17,716,000	–	400,000	+100.0%	0.58%	–
	New	ABBVIE INCput	$16,211,000	–	100,000	+100.0%	0.53%	–
	New	VAREX IMAGING CORPput	$15,968,000	–	750,000	+100.0%	0.52%	–
	New	SAREPTA THERAPEUTICS INCcall	$15,624,000	–	200,000	+100.0%	0.51%	–
	New	COOPER COS INCcall	$15,576,000	–	37,300	+100.0%	0.50%	–
	New	RESMED INCput	$13,944,000	–	57,500	+100.0%	0.45%	–
	New	ISHARES TRcall	$13,030,000	–	100,000	+100.0%	0.42%	–
	New	ENVISTA HOLDINGS CORPORATIONput	$12,665,000	–	260,000	+100.0%	0.41%	–
	New	CVS HEALTH CORPput	$12,520,000	–	123,700	+100.0%	0.41%	–
	New	HEALTHEQUITY INCcall	$12,139,000	–	180,000	+100.0%	0.39%	–
	New	MOLSON COORS BEVERAGE COput	$11,653,000	–	218,300	+100.0%	0.38%	–
	New	NATERA INCcall	$11,187,000	–	275,000	+100.0%	0.36%	–
	New	AVANTOR INCput	$10,992,000	–	325,000	+100.0%	0.36%	–
TECH	New	BIO-TECHNE CORP	$10,826,000	–	25,000	+100.0%	0.35%	–
AMRS	New	AMYRIS INC	$10,732,000	–	2,461,436	+100.0%	0.35%	–
	New	APELLIS PHARMACEUTICALS INCcall	$10,162,000	–	200,000	+100.0%	0.33%	–
	New	QUANTERIX CORPcall	$10,059,000	–	344,600	+100.0%	0.33%	–
	New	AGILENT TECHNOLOGIES INCput	$9,925,000	–	75,000	+100.0%	0.32%	–
	New	SELECT SECTOR SPDR TRput	$9,486,000	–	125,000	+100.0%	0.31%	–
	New	EXACT SCIENCES CORPcall	$9,439,000	–	135,000	+100.0%	0.31%	–
	New	THE BEAUTY HEALTH COMPANYcall	$8,847,000	–	524,100	+100.0%	0.29%	–
	New	MODERNA INCcall	$8,613,000	–	50,000	+100.0%	0.28%	–
	New	GUARDANT HEALTH INCput	$8,611,000	–	130,000	+100.0%	0.28%	–
	New	ALNYLAM PHARMACEUTICALS INCput	$8,165,000	–	50,000	+100.0%	0.26%	–
	New	PRIVIA HEALTH GROUP INCcall	$8,019,000	–	300,000	+100.0%	0.26%	–
IMUX	New	IMMUNIC INC	$7,721,000	–	683,287	+100.0%	0.25%	–
	New	WALGREENS BOOTS ALLIANCE INCcall	$7,163,000	–	160,000	+100.0%	0.23%	–
	New	AZENTA INCput	$7,003,000	–	84,500	+100.0%	0.23%	–
	New	STAAR SURGICAL COcall	$6,792,000	–	85,000	+100.0%	0.22%	–
EVH	New	EVOLENT HEALTH INCcl a	$6,460,000	–	200,000	+100.0%	0.21%	–
	New	SOPHIA GENETICS SAordinary shares	$6,415,000	–	829,930	+100.0%	0.21%	–
	New	SCHRODINGER INCcall	$6,312,000	–	185,000	+100.0%	0.20%	–
	New	GINKGO BIOWORKS HOLDINGS INCput	$6,045,000	–	1,500,000	+100.0%	0.20%	–
	New	GILEAD SCIENCES INCput	$5,945,000	–	100,000	+100.0%	0.19%	–
	New	BEAM THERAPEUTICS INCput	$5,730,000	–	100,000	+100.0%	0.19%	–
RCEL	New	AVITA MEDICAL INC	$5,718,000	–	674,316	+100.0%	0.18%	–
COO	New	COOPER COS INC	$5,429,000	–	13,000	+100.0%	0.18%	–
	New	SCIENCE 37 HOLDINGS INC	$5,384,000	–	1,006,400	+100.0%	0.18%	–
	New	ZTSput	$5,281,000	–	28,000	+100.0%	0.17%	–
	New	APELLIS PHARMACEUTICALS INCput	$5,081,000	–	100,000	+100.0%	0.16%	–
RCM	New	R1 RCM INC	$5,043,000	–	188,455	+100.0%	0.16%	–
	New	C4 THERAPEUTICS INCcall	$4,852,000	–	200,000	+100.0%	0.16%	–
	New	ACADIA PHARMACEUTICALS INCcall	$4,844,000	–	200,000	+100.0%	0.16%	–
	New	GREENLIGHT BIOSCIENCS HLDS P	$3,852,000	–	400,000	+100.0%	0.12%	–
	New	AVITA MEDICAL INCcall	$3,816,000	–	450,000	+100.0%	0.12%	–
	New	TELADOC HEALTH INCput	$3,607,000	–	50,000	+100.0%	0.12%	–
	New	IMMUNIC INCput	$3,390,000	–	300,000	+100.0%	0.11%	–
TGTX	New	TG THERAPEUTICS INC	$3,121,000	–	328,187	+100.0%	0.10%	–
	New	INMODE LTDput	$3,100,000	–	84,000	+100.0%	0.10%	–
FLDM	New	FLUIDIGM CORP DEL	$3,052,000	–	850,000	+100.0%	0.10%	–
	New	INTEGER HLDGS CORPput	$3,021,000	–	37,500	+100.0%	0.10%	–
ICAD	New	ICAD INC	$3,002,000	–	672,989	+100.0%	0.10%	–
	New	IGM BIOSCIENCES INCcall	$2,673,000	–	100,000	+100.0%	0.09%	–
	New	ANAVEX LIFE SCIENCES CORPcall	$2,462,000	–	200,000	+100.0%	0.08%	–
	New	NANO X IMAGING LTDput	$2,168,000	–	200,000	+100.0%	0.07%	–
PTON	New	PELOTON INTERACTIVE INC	$2,114,000	–	80,000	+100.0%	0.07%	–
ADPT	New	ADAPTIVE BIOTECHNOLOGIES COR	$2,082,000	–	150,000	+100.0%	0.07%	–
	New	ALNYLAM PHARMACEUTICALS INCcall	$2,008,000	–	12,300	+100.0%	0.06%	–
AZN	New	ASTRAZENECA PLCsponsored adr	$1,990,000	–	30,000	+100.0%	0.06%	–
SRPT	New	SAREPTA THERAPEUTICS INC	$2,019,000	–	25,850	+100.0%	0.06%	–
UBX	New	UNITY BIOTECHNOLOGY INC	$1,768,000	–	1,578,140	+100.0%	0.06%	–
SDGR	New	SCHRODINGER INC	$1,706,000	–	50,000	+100.0%	0.06%	–
	New	RUBIUS THERAPEUTICS INCcall	$1,653,000	–	300,000	+100.0%	0.05%	–
	New	ARCUS BIOSCIENCES INCcall	$1,578,000	–	50,000	+100.0%	0.05%	–
PTGX	New	PROTAGONIST THERAPEUTICS INC	$1,548,000	–	65,371	+100.0%	0.05%	–
TCDA	New	TRICIDA INC	$1,486,000	–	180,816	+100.0%	0.05%	–
MAPS	New	WM TECHNOLOGY INC	$1,392,000	–	178,000	+100.0%	0.04%	–
	New	CORTEXYME INCcall	$1,238,000	–	200,000	+100.0%	0.04%	–
	New	CARDINAL HEALTH INCput	$1,134,000	–	20,000	+100.0%	0.04%	–
GBT	New	GLOBAL BLOOD THERAPEUTICS IN	$1,020,000	–	29,454	+100.0%	0.03%	–
	New	GERON CORPcall	$956,000	–	702,600	+100.0%	0.03%	–
	New	UNITY BIOTECHNOLOGY INCcall	$878,000	–	783,800	+100.0%	0.03%	–
	New	AGENUS INCcall	$858,000	–	348,800	+100.0%	0.03%	–
	New	CUE HEALTH INCput	$739,000	–	114,500	+100.0%	0.02%	–
TXMD	New	THERAPEUTICSMD INC	$615,000	–	1,619,080	+100.0%	0.02%	–
	New	TRAVERE THERAPEUTICS INCnote 2.250% 3/0	$532,000	–	5,000	+100.0%	0.02%	–
	New	CULLINAN ONCOLOGY INCput	$481,000	–	45,900	+100.0%	0.02%	–
	New	PROQR THRAPEUTICS N Vcall	$252,000	–	277,900	+100.0%	0.01%	–
CSII	New	CARDIOVASCULAR SYS INC DEL	$247,000	–	10,911	+100.0%	0.01%	–
	New	AMYLYX PHARMACEUTICALS INC	$129,000	–	10,000	+100.0%	0.00%	–
GLYC	New	GLYCOMIMETICS INC	$100,000	–	87,678	+100.0%	0.00%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2022-05-16

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Financial Officer and Chief Compliance Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13
SC 13D/A	2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export PURA VIDA INVESTMENTS, LLC's holdings